Iveena Delivery Systems, Inc.
Publicly observedSalt Lake City, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Salt Lake City | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Iveena Delivery Systems, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | EQ3KNDP93M27 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant30 Sept 2023Publicly observed
NIH SBIR/STTR award: Topical Eyedrops Increasing Lysyl Oxidase and Dopamine Activity to Control Myopia
USD 1,111,998.00 · National Eye Institute · Source: NIH RePORTER (opens in a new tab)
- Grant30 Sept 2023Publicly observed
NIH SBIR/STTR award: Topical Eyedrops Increasing Lysyl Oxidase and Dopamine Activity to Control Myopia
USD 933,817.00 · National Eye Institute · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.